Servier at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Servier takes part in 2 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8064. Its program centres on metastatic uveal melanoma, a melanoma of the eye, moving from the biology of the disease to practical treatment. It also covers real-world cases and patient-centred care in gastrointestinal cancers.

OrganizationESMO 2026 Attendance
servier.com
Large pharmaExhibitor
French pharmaceutical group whose oncology medicines include vorasidenib for IDH-mutant glioma and treatments for colorectal and pancreatic cancer and leukaemia.
Booth
Exhibiting at Booth 8064
Satellite
Fri Oct 23
18:15–19:45
Satellite
Sat Oct 24
13:00–14:30
Servier - GI Oncology in Motion : Real-World Cases and Patient Centric Care
Sponsored session · with Hospital Universitario Fundación Jiménez Díaz, Medical University of Vienna
Gastrointestinal cancersBiomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Servier

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction